IGF2BP3 and hepatocellular carcinoma: Altogether, our study reveals that NC may exert anti-HCC effects through the IGF2BP3/m6A/metabolic gene regulatory axis, which contributes to further research and clinical applications of NC as an anti-HCC treatment.